Patient Advocate, AUDT
Biography
Karen Merritt is an impassioned patient advocate. Having lost her mother in 2014 after fatal toxicity from 5-FU chemotherapy due to an unknown DPD Deficiency, Karen is dedicated to advocating for pretesting for DPD Deficiency before fluoropyrimidine chemotherapy administration. Founding member of Advocates for Universal DPD/DPYD Testing (AUDT). As a Patient Representative, Karen is a member of ClinGen PGx Working Group as well as Standardizing Laboratory Practices in Pharmacogenomics (STRIPE)
Talk
Human Cost of Ignoring DPD Deficiency
Demonstrated clinical benefits show pretreatment DPYD testing increases patient safety, improves quality of care and saves money. Tragic to lose a loved one to cancer, but even more tragic when the death could have been prevented with a simple cheek swab. Time to pretest for DPD Deficiency.
Session Abstract – PMWC 2023 Silicon Valley
Track 1 - January 27 9.00 A.M.-4.15 P.M.
Track Co-Chair:
Mary Relling, St. Jude
Pharmacists have long recognized that using unique patient characteristics to guide pharmacotherapy decision-making can improve drug response and mitigate drug-associated risks. Age, weight, and dietary habits were among the first patient-specific characteristics used to individualize pharmacotherapy. As technologies advanced, analytic tools that measure surrogate markers of liver and renal function, together with drug concentrations in biological fluids, were adopted to optimize therapeutic regimens. Cutting-edge genomic technologies are now being integrated into patient care for the selection of targeted therapies and identification of those at increased risk of poor pharmacotherapy outcomes. We’re excited to bring together experts who are advancing pharmacogenomics at scale through cutting edge clinical implementation, research, and education.
- PMWC 2023 PGx Award Ceremony:
Pioneer Honoree: Dan Roden, Vanderbilt University Medical Center
Luminary Honoree: Kelly E. Caudle, St. Jude
- Fireside Chat:
PMWC 2023 Pioneer Honoree Dan Roden, Vanderbilt University Medical Center with Mary Relling, St. Jude - Keynote by PMWC 2023 Luminary Honoree:
- Kelly E. Caudle, St. Jude - Fireside Chat:
Chair: Damon Hostin, Illumina
- Howard McLeod, Intermountain Health - Laboratory Testing and Reports
Chair: Kristy Crooks, University of Colorado
- Ann M. Moyer, Mayo Clinic
- Stuart Scott, Stanford University
- Implementation of PGx at UCSF
- Bani Tamraz, UCSF
- From Economics to Reimbursement (PANEL)
Chair: Sara Rogers, American Society of Pharmacovigilance
- Stirling Bryan, The University of British Columbia
- Ray Stultz, Optum
- Gabriel Bien-Willner, Palmetto GBA
- Policy Efforts to Address Barriers to PGx Adoption
Chair: Kristine Ashcraft, Invitae
- Pam Traxel, ACS CAN - PGx Practice Liability
Chair: Dan Hertz, University of Michigan
- Anthony Morreale, VA, San Diego
- Karen Merritt, Patient Advocate - Diversity, Equity, and Inclusion in Pharmacogenomics Implementation
- Carlos Bustamante, Galatea Bio
- Kathy Giacomini, UCSF - Implementation of PGx Program & PGx Clinic Services in a Large Rural Healthcare Setting
- April Schultz, Sanford
